Outbreaks of emerging infections present health professionals with the unique challenge of
trying to select appropriate pharmacologic treatments in the clinic with little time available for …

The global emergence of many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variants jeopardizes the protective antiviral immunity induced after infection or …

The potential for future coronavirus outbreaks highlights the need to broadly target this group
of pathogens. We used an epitope-agnostic approach to identify six monoclonal antibodies …

Middle East respiratory syndrome coronavirus (MERS-CoV) is a lineage C betacoronavirus,
and infections with this virus can result in acute respiratory syndrome with renal failure. …

We describe an antiviral small molecule, LJ001, effective against numerous enveloped
viruses including Influenza A, filoviruses, poxviruses, arenaviruses, bunyaviruses, …

The Middle East respiratory syndrome coronavirus (MERS-CoV) presents a novel emerging
threat to public health worldwide. Several treatments for infected individuals have been …

In addition to patient A, survivor A reported recent unprotected vaginal intercourse with a
woman aged 45 years (contact A) with no history of illness. Intercourse with contact A occurred …

Flaviviruses transmitted by arthropods represent a tremendous disease burden for humans,
causing millions of infections annually. All vector-borne flaviviruses studied to date suppress …

The phosphoinositide-3 kinase (PI3K) pathway regulates diverse cellular activities related to
cell growth, migration, survival, and vesicular trafficking. It is known that Ebola virus requires …

The recent emergence of multiple SARS‐CoV‐2 variants has caused considerable concern
due to both reduced vaccine efficacy and escape from neutralizing antibody therapeutics. It is…